Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study.

Nounu, A; Richmond, RC; Stewart, ID; Surendran, P; Wareham, NJ; Butterworth, A; Weinstein, SJORCID logo; Albanes, D; Baron, JA; Hopper, JL; +55 more...Figueiredo, JCORCID logo; Newcomb, PA; Lindor, NM; Casey, G; Platz, EA; Marchand, LLORCID logo; Ulrich, CMORCID logo; Li, CI; van Dujinhoven, FJ; Gsur, AORCID logo; Campbell, PT; Moreno, VORCID logo; Vodicka, P; Vodickova, L; Amitay, E; Alwers, E; Chang-Claude, J; Sakoda, LCORCID logo; Slattery, ML; Schoen, RE; Gunter, MJ; Castellví-Bel, SORCID logo; Kim, H; Kweon, S; Chan, AT; Li, L; Zheng, W; Bishop, DT; Buchanan, DDORCID logo; Giles, GG; Gruber, SB; Rennert, G; Stadler, ZK; Harrison, TA; Lin, Y; Keku, TO; Woods, MO; Schafmayer, C; Van Guelpen, B; Gallinger, S; Hampel, H; Berndt, SI; Pharoah, PD; Lindblom, A; Wolk, A; Wu, AH; White, E; Peters, U; Drew, DA; Scherer, D; Bermejo, JLORCID logo; Brenner, H; Hoffmeister, MORCID logo; Williams, AC; Relton, CLORCID logo and (2021) Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study. Nutrients, 13 (11). p. 4164. ISSN 2072-6643 DOI: 10.3390/nu13114164
Copy

Salicylic acid (SA) has observationally been shown to decrease colorectal cancer (CRC) risk. Aspirin (acetylsalicylic acid, that rapidly deacetylates to SA) is an effective primary and secondary chemopreventive agent. Through a Mendelian randomization (MR) approach, we aimed to address whether levels of SA affected CRC risk, stratifying by aspirin use. A two-sample MR analysis was performed using GWAS summary statistics of SA (INTERVAL and EPIC-Norfolk, N = 14,149) and CRC (CCFR, CORECT, GECCO and UK Biobank, 55,168 cases and 65,160 controls). The DACHS study (4410 cases and 3441 controls) was used for replication and stratification of aspirin-use. SNPs proxying SA were selected via three methods: (1) functional SNPs that influence the activity of aspirin-metabolising enzymes; (2) pathway SNPs present in enzymes' coding regions; and (3) genome-wide significant SNPs. We found no association between functional SNPs and SA levels. The pathway and genome-wide SNPs showed no association between SA and CRC risk (OR: 1.03, 95% CI: 0.84-1.27 and OR: 1.08, 95% CI: 0.86-1.34, respectively). Results remained unchanged upon aspirin use stratification. We found little evidence to suggest that an SD increase in genetically predicted SA protects against CRC risk in the general population and upon stratification by aspirin use.


picture_as_pdf
Nounu-etal-2021-Salicylic-acid-and-risk-of-colorectal-cancer.pdf
subject
Published Version
Available under Creative Commons: Attribution 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads